Results 21 to 30 of about 3,850,355 (295)
Biomarkers of Mucinous Tumors of the Ovary [PDF]
Disease Markers, 2007 Goli Samimia,b, Laurent Ozbunb, Michael E. Johnsonc, Samuel C. Mokc and Michael J. Birrerb Cancer Prevention Fellowship Program, National Cancer Institute, Bethesda, MD 20892, USA Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA Laboratory of Gynecologic Oncology, Brigham and Women’s ...
Samimi, Goli +4 more
openaire +4 more sources
Journal of Extracellular Biology, 2022 Detection of cell‐free circulating tumour DNA (ctDNA) and cancer‐specific extracellular vesicles (EVs) in patient blood have been widely explored as non‐invasive biomarkers for cancer detection and disease follow up.
Mercedes Tkach +7 more
doaj +1 more source
Tomography, 2023 Patients with degenerative cervical myelopathy (DCM) undergo adaptive supraspinal changes. However, it remains unknown how subcortical white matter changes reflect the gray matter loss.
Chencai Wang +6 more
doaj +1 more source
Biomarkers of Tumor Metastasis and Invasiveness
Cancers, 2023 The identification of proteins as new cancer diagnostic and prognostic biomarkers continues to attract considerable attention in the oncology literature, especially in the context of invasion and metastasis activation process [...]
Daniel L. Pouliquen +1 more
openaire +3 more sources
Identifying the Risk Factors for Malignant Mammary Tumors in Dogs: A Retrospective Study
Veterinary Sciences, 2023 Mammary cancer is one of the main causes of death in female dogs worldwide, considering that many risk factors are involved in its development. This study aimed to elucidate the relationship between epidemiological and clinical risk factors with the ...
Elis Maressa Gonçalves da Silva +2 more
doaj +1 more source
Biomarkers in neuroendocrine tumors
Frontiers in Bioscience, 2010 Here, we review the role of clinical biomarkers (tissue and circulating markers) in the management of neuroendocrine tumors. These tumors may originate in different organs, from cells embriologically different but expressing common phenotypic characteristics, such as the immuno-reactivity for markers of neuro endocrine differentiation (defined as "pan ...
BERRETTA M +7 more
openaire +6 more sources
Renal tumor biomarkers (Review)
Experimental and Therapeutic Medicine, 2021 One of the most common types of cancer worldwide (9th most commonly diagnosed) is renal cell carcinoma (RCC). It is more common in developed countries and it usually develops in individuals between 60 and 70 years of age. The earlier the disease is identified, the lower the morbidity.
Ovidiu Gabriel Bratu +11 more
openaire +4 more sources
Cancer Control, 2009 Background Morphologic and histopathologic markers have been the backbone for the classification and prognostic assessment of melanoma. Availability of an increasing number of molecular markers, however, provides the potential for refining diagnostic and prognostic categories in this disease.
Jüurgen C Becker +2 more
openaire +3 more sources
Zyxin expression levels in non-small cell lung cancer patients [PDF]
Vojnosanitetski Pregled, 2020 Background/Aim. Non-small cell lung cancer (NSCLC) is the most common cause of cancer-related mortality worldwide. Early detection represents one of the most promising approaches to reduce lung cancer mortality.
Ilić Dejan +4 more
doaj +1 more source
CD44 as a tumor biomarker and therapeutic target [PDF]
Experimental Hematology & Oncology, 2020 AbstractCD44, a complex transmembrane glycoprotein, exists in multiple molecular forms, including the standard isoform CD44s and CD44 variant isoforms. CD44 participates in multiple physiological processes, and aberrant expression and dysregulation of CD44 contribute to tumor initiation and progression. CD44 represents a common biomarker of cancer stem
Kongming Wu +5 more
openaire +3 more sources